K
Kai Du
Researcher at University of Toronto
Publications - 13
Citations - 3234
Kai Du is an academic researcher from University of Toronto. The author has contributed to research in topics: Cystic fibrosis transmembrane conductance regulator & Chloride channel. The author has an hindex of 13, co-authored 13 publications receiving 3055 citations. Previous affiliations of Kai Du include McGill University.
Papers
More filters
Journal ArticleDOI
Small-molecule correctors of defective ΔF508-CFTR cellular processing identified by high-throughput screening
Nicoletta Pedemonte,Gergely L. Lukacs,Kai Du,Emanuela Caci,Olga Zegarra-Moran,Luis J. V. Galietta,Alan S. Verkman +6 more
TL;DR: Screening of 150,000 chemically diverse compounds and more than 1,500 analogs of active compounds yielded several classes of DeltaF508-CFTR correctors with micromolar potency that produced greater apical membrane chloride current than did low-temperature rescue.
Journal ArticleDOI
Curcumin, a Major Constituent of Turmeric, Corrects Cystic Fibrosis Defects
Marie E. Egan,Marilyn Pearson,Scott A. Weiner,Vanathy Rajendran,Daniel Rubin,Judith Glöckner-Pagel,Susan Canny,Kai Du,Gergely L. Lukacs,Michael J. Caplan +9 more
TL;DR: Curcumin treatment may be able to correct defects associated with the homozygous expression of ΔF508 CFTR, which results in the production of a misfolded CFTR protein that is retained in the endoplasmic reticulum and targeted for degradation.
Journal ArticleDOI
Peripheral Protein Quality Control Removes Unfolded CFTR from the Plasma Membrane
Tsukasa Okiyoneda,Herve Barriere,Miklós Bagdány,Wael M. Rabeh,Kai Du,Jörg Höhfeld,Jason C. Young,Gergely L. Lukacs +7 more
TL;DR: Using functional small-interfering RNA screens in cells expressing the common cystic fibrosis mutation F508CFTR, the authors identified a pair of chaperones that promoted clearance of defective proteins from the plasma membrane that will also need to be overcome to increase the effectiveness of strategies to overcome protein misfolding disorders.
Journal ArticleDOI
The ΔF508 cystic fibrosis mutation impairs domain-domain interactions and arrests post-translational folding of CFTR
TL;DR: It is suggested that hydrophobic side chain interactions of Phe508 are required for vectorial folding of NBD2 and the domain-domain assembly of CFTR, representing a combined co- and post-translational folding mechanism that may be used by other multidomain membrane proteins.
Journal ArticleDOI
Misfolding diverts CFTR from recycling to degradation quality control at early endosomes
Manu Sharma,Francesca Pampinella,Csilla Nemes,Mohamed Benharouga,Jeffrey So,Kai Du,Kristi G. Bache,Blake C. Papsin,Noa Zerangue,Harald Stenmark,Gergely L. Lukacs +10 more
TL;DR: It is shown that the folding state of CFTR determines the post-endocytic trafficking of the channel and a paradigm for the quality control of plasma membrane proteins involving the coordinated function of ubiquitination and the Ub-dependent endosomal sorting machinery is suggested.